Trials / Completed
CompletedNCT02157155
A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis
The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis 1. To define whether stimulation of ATGL and suppression of G0/G1 switch gene occur in the initial phases of diabetic ketoacidosis and thus can be identified as the primary mechanisms behind this life threatening condition. 2. Make a human model for studying ketoacidosis. The investigators plan to reduce in their regular insulin over night. In the morning we administer endotoxin, which together with a relative lack of insulin will initiate ketogenesis - a state of ketoacidosis. On another occasion strict glycemic control is imposed by means of intravenous insulin. The testing is done two separate days with at least 3 weeks in between and patients are admitted to hospital the evening before the day of testing. The investigators use isotopic tracers to determine metabolic fluxes and analyse fat (ATGL, G0/G1 switch gene) and muscle biopsies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LPS | LPS is endotoxin from gram negative bacteria. It is used scientifically to mimic infection lasting 4-8 hours. |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-03-01
- Completion
- 2015-09-01
- First posted
- 2014-06-05
- Last updated
- 2015-12-02
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02157155. Inclusion in this directory is not an endorsement.